Objective: Volume-outcome relationships for esophageal cancer resection have been well described with centers of excellence defined by volume. No consensus exists for what constitutes a ''high-volume'' center. We aim to determine if an objective evidence-based threshold of operative volume associated with improvement in operative outcome for esophageal resections can be defined.
Objective: Volume-outcome relationships for esophageal cancer resection have been well described with centers of excellence defined by volume. No consensus exists for what constitutes a ''high-volume'' center. We aim to determine if an objective evidence-based threshold of operative volume associated with improvement in operative outcome for esophageal resections can be defined.
Methods: Retrospective analysis was performed on patients undergoing esophageal resection for cancer in the 1998 to 2005 Nationwide Inpatient Sample. A series of multivariable analyses were performed, changing the resection volume cutoff to account for the range of annual hospital resections. The goodness of fit of each model was compared by pseudo r 2 , the amount of data variance explained by each model.
Results: A total of 4080 patients underwent esophageal resection. The median annual hospital resection volume was 4 (range: 1-34). The mortality rate of ''high-volume'' centers ranged from 9.94% (2 resection/year) to 1.56% (30 resections/year). The best model was with an annual hospital resection volume greater than or equal to 15 (3.87% of data variance explained). The difference in goodness of fit between the best model and other models with different volume cutoffs was 0.64%, suggesting that volume explains less than 1% of variance in perioperative death.
Conclusion:
Our data do not support the use of volume cutoffs for defining centers of excellence for esophageal cancer resections. Although volume has an incremental impact on mortality, volume alone is insufficient for defining centers of excellence. Volume seems to function as an imperfect surrogate for other variables, which may better define centers of excellence. Additional work is needed to identify these variables.
See related article on page 10.
Resection of the esophagus, either total or partial, is a complex surgical procedure that carries a relatively high risk of operative mortality. Because of this, a significant body of work has focused on the relationship between volume and outcome for esophageal resections. The beneficial effect of increased volume of esophagectomy on outcome has been clearly demonstrated in multiple studies. [1] [2] [3] [4] On the basis of the results of these and similar studies, esophageal resection has been identified as a potential procedure for volumebased regionalization, and as such resection volume has been proposed as a measurement for defining centers of excellence. An example of this is the Leapfrog Group, which defined criteria for ''evidence-based hospital referral'' for esophageal resection as hospitals performing a minimum of 13 resections per year. 5 In addition to the volume cutoff for esophageal resections set by the Leapfrog Group, various other thresholds for defining high-volume centers have been used in the literature. These annual hospital volume thresholds range from 6 to 20 esophageal resections per year. 2, 6, 7 However, these cutoff points have often been imprecisely or arbitrarily defined, and there are little data to support the use of specific volume cutoffs.
The aim of this study was to determine if an objective, evidence-based threshold of operative volume associated with improved hospital-level outcomes for esophageal resection for cancer could be defined. Should this threshold be identified, it could potentially be considered a candidate in the criteria for defining high-volume hospitals for esophageal resection.
MATERIALS AND METHODS Data Source
A retrospective analysis was performed using patient data collected from the Nationwide Inpatient Sample (NIS) file between 1998 and 2003. The NIS database comprises discharge records approximating a 20% sample of hospital discharges in the United States and is maintained by the Agency for Healthcare Research and Quality as part of the Healthcare Cost and Utilization Project. 8 It approximates 7 million patient discharge records per year, originating from approximately 1000 different hospitals per year nationwide. Data available within the NIS include patient and hospital demographics, payer information, treating and concomitant diagnoses, inpatient
Patient Population
Initial inclusion criteria for this study were patients from the NIS database older than 17 years of age admitted with the diagnosis of esophageal cancer as identified by the International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes (150.X).
10 Inclusion criteria was further limited to patients who underwent esophageal resection as identified by ICD-9 Clinical Modification procedure codes of 42.4 and 42.40 (esophagectomy NOS), 42.41 (partial esophagectomy), 42.42 (total esophagectomy), and 43.99 (esophagogastrectomy). 2 
Statistical Analysis
Multivariable analysis was performed with in-hospital death as the outcome of record from the discharge summaries. Independent variables included annual hospital resection volume, teaching status of the hospital where the procedure was performed, the year the procedure was performed, patient age, gender, race, and comorbidities as measured by the Charlson Index. The NIS dataset defines teaching hospital status as hospitals that have any American Medical Association-approved residency program, belong to the Council of Teaching Hospitals, or have a ratio of no more than 4:1 beds to full-time equivalent interns and residents.
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Patient comorbidities were standardized via calculation of the Deyo modification of the Charlson Index 12,13 per the methods of Romano and colleagues.
14 A standardized calculation of patient health, the Charlson Index is determined by weighted scoring of comorbidities, including cardiac, vascular, pulmonary, neurologic, endocrine, renal, hepatic, gastrointestinal, and immune diseases, as well as any documented history of cancer.
Individual annual hospital procedure volume was determined by calculating the number of esophageal resections performed using NIS-assigned unique hospital identification numbers. The annual hospital mortality rate for esophageal resections was calculated using the NIS annual hospital resection volume for esophageal resections.
Esophageal resection volume was included as a dichotomous variable to identify the volume cutoff that best models outcome. A series of sequential multiple logistic regression models with a dependent variable of in-hospital death; a set of common independent variables including patient age, gender, race, and Charlson Index of comorbidities, procedure year, and hospital teaching status; and a sequentially changing independent variable of dichotomized annual hospital resection volume were tested. This sequentially changing variable of annual hospital resection volume was dichotomized at 2 continuously up to 34, accounting for all of the esophageal resections in the NIS database in the time period studied. The resection volumes within this range are nearly continuous.
Each volume threshold dichotomizes the data and creates 2 categories for comparison: hospitals with an annual resection volume less than that cutoff and hospitals with an annual resection volume greater than or equal to that cutoff. Each volume threshold is then taken forward in the multivariable regression analysis as the independent variable.
Statistical analysis was performed using the software package STATA 10.0 (StataCorp LP, College Station, Tex). Bivariate analysis of categoric data was performed using the chi-square test. Analysis of continuous data was performed using the Student t test. Multivariable analysis was performed using linear and logistic regression models. 
RESULTS

Patient Population
Analysis of the NIS dataset identified 53,168 patients with the diagnosis of esophageal cancer, of whom 4080 (7.7%) underwent esophageal resection, as defined by the previously listed ICD-9 Clinical Modification codes. Of these patients, 79.6% were male, and the median age was 64 years. These esophagectomies were performed at 1506 hospitals. The median annual hospital resection volume was 4, with the range from 1 to 34 (interquartile range 2-9). Of the patients studied, 83.9% were white, 8.8% were black, and the remainder were of unreported race. A total of 2883 patients (70.7%) underwent resection at teaching hospitals. The median Charlson Comorbidity Index for the 4080 patients studied was 3, with an interquartile range of 2 to 8 and a range of 2 to 14 (of a possible range from 0 to 33). Between 444 and 552 patients underwent esophageal resection per year. There were 387 in-hospital deaths for this patient group, resulting in an overall in-hospital mortality rate of 9.49%. See Table 1 for demographics.
Hospital Volume-Mortality Relationship
The unadjusted annual in-hospital mortality rate was calculated for each hospital. This ranged between 0% and 100%, with a median value of 0 and a mean value of 11.5% ( Figure 1 ).
In-Hospital Mortality
A series of multiple logistic regression models were tested with a dependent variable of in-hospital death and common independent variables, including patient age, gender, race, and Charlson Index of comorbidities, procedure year, and hospital teaching status. In each model a sequentially changing variable of annual hospital resection volume threshold was inserted, dichotomizing volume into ''less than'' versus ''greater than or equal to'' that volume threshold. The mortality of patients at ''high-volume'' and ''low-volume'' hospitals defined at each threshold level and the various representations of goodness of fit (McFadden's pseudo r 2 and AUC of that particular multiple logistic regression model) are presented in Table 2 .
The values represent the average mortality rate for all hospitals with esophagectomy volumes less than the volume threshold, as well as the average mortality rate for all hospitals with esophagectomy volumes greater than or equal to the volume threshold. An example of interpretation of the values for a volume threshold of 15 would signify that hospitals that perform greater than or equal to 15 resections per year have an average postoperative mortality rate of 5.30% compared with an average postoperative mortality rate of 10.16% at hospitals that perform less than 15 esophageal resections per year (P < .001). Comparison of mortality rates of hospitals with annual esophagectomy volumes for esophageal cancer above and below each volume threshold reveals that they are significantly different for all volume thresholds compared (P < .05), except when volume is greater than or equal to 29 esophagectomies/year (P ¼ .08) and greater than or equal to 34 esophagectomies/year (P ¼ .19). These results are depicted graphically in Figure 2 .
The goodness of fit of different models with different volume thresholds, as measured by McFadden's pseudo r 2 , ranged from a baseline of 3.23%, where the volume variable is not included in the model, to 3.87%. The models with the best fit to data were those that defined high-volume threshold at 15 and 16, with McFadden's pseudo r 2 of 0.0387 or 3.87%. It should be noted that when the volume threshold was set at 13, as suggested by the Leapfrog Group, the resulting model had a McFadden's pseudo r 2 of 3.80%. A graphic depiction of the changes in goodness of fit as defined by McFadden's pseudo r 2 of different volume thresholds is shown in Figure 3 . The goodness of fit for the dichotomous model improved as the volume threshold was increased from 1 to 15, peaking at a threshold of 15 resections per year. Subsequently, the goodness of fit of the model deteriorated as the volume threshold was further increased.
The results from calculation of the AUC as a measure of goodness of fit are reported in Table 2 . The range in the calculated values of AUC is similar to that of the McFadden's pseudo r 2 ; therefore, our discussion focuses on the results of the McFadden's pseudo r 2 .
CONCLUSIONS
Much attention has been focused on defining centers of excellence. To date, the role of hospital volume has been emphasized. By using the NIS dataset, we examined the relationship between surgical volume and mortality. We found this well-established inverse relationship persists in the NIS dataset. This is demonstrated in Figure 1 , where a clear trend toward diminishing unadjusted annual in-hospital mortality is present.
Given the well-established inverse relationship between esophageal resection volume and in-hospital mortality, we sought to use statistical modeling to define a single value cutoff at which there is significantly reduced mortality. This would allow us to better determine hospital operative volumes required for improved outcomes for esophageal resection for cancer.
On analysis of dichotomous volume cutoff modeling, we found a statistically significant difference between mortality rates at hospitals with esophagectomy volumes above the volume threshold in comparison with mortality rates of hospitals with esophagectomy volumes below the volume threshold, irrespective of annual hospital resection volume cutoff ( Figure 2 ). For example, defining high volume at 13 or more, as suggested by the Leapfrog Group, 5 the resulting high-volume hospitals have a mortality rate of 5.39% in comparison with 10.26% at low-volume hospitals (P < .001). However, even defining the high-volume threshold at a volume of 2 resections per year produces significant differences in mortality rates between hospitals with esophagectomy volumes above and below that threshold. Our study confirms previous findings by Christian and colleagues, 18 who also showed that the Leapfrog standards may not have been optimal for other surgical procedures; for example, they empirically found different thresholds for coronary artery bypass graft, abdominal aortic aneurysm, and esophagectomies compared with the Leapfrog standards; moreover, in contrast with Leapfrog, they found no good empiric threshold for carotid endarterectomies.
This finding reveals the true conundrum of volume modeling: No matter what the volume cutoff is set at, the mortality rates above and below it are almost always significantly different. Therefore, to determine the best model for highvolume centers, we examined goodness of fit of the model to the data instead of differences in mortality.
When multiple logistic regression of in-hospital death after esophageal resection includes the variables of patient age, gender, race, and Charlson Index of comorbidities and calendar year, but not resection volume, the resulting model explains 3.23% of the variance in the data. Adding hospital volume as a dichotomous variable, ranging from 2 to 34 resections per year, improves the explanatory power of the model, with pseudo r 2 ranging between 3.35% and 3.87%. By using these criteria, the best model is one that defines a ''high-volume'' cutoff as 15 or more esophageal resections per hospital per year, because this has the highest McFadden's pseudo r 2 value and accounts for the most variability in the data. It is interesting to note that the inclusion of volume into the multivariable model only accounts for a maximum of 0.64% of the variability in the data. Therefore, varying the volume threshold did not substantially change the explanatory power of the different dichotomous volume models for defining high-volume centers for esophageal resection. This is noteworthy given the attention that resection volume for esophageal surgery, among other procedures, has been afforded in the literature.
Although there is an overall trend of increased operative volume associated with decreased postoperative mortality, a curious finding is present in Table 2 : The mortality rate at centers with annual resection volumes equal to or greater than the volume threshold tested do not necessarily have continuously diminishing values. The mortality rates given in Table 2 are calculated by averaging the mortality rates of every hospital that performs esophagectomies above or below the volume threshold. As can be seen, increased volume does not strictly correlate with decreased postoperative, in-hospital mortality. Therefore, factors other than annual hospital volume must certainly contribute to mortality rate.
The NIS database was chosen over other available databases because of the extensive nature of its records and the ability to provide a large sample size with which to compare outcomes across the United States. As in analyses of all administrative databases, the current analysis has several limitations. They include the retrospective database design and the associated constraints at the level of the data used for analysis, the inability to account for surgeon experience, the difficulty in examining other postoperative outcomes such as cause of death, and the inability to measure 30-day mortality, as opposed to in-hospital death. In examining the NIS database, we are unable to check the accuracy of the diagnostic and procedure coding. Although the validity of the coding may be verified, the appropriateness of the coding used for diagnosis and procedures may not. However, we assume that this type of error would be equally distributed across all groups of interest. The overall in-hospital mortality rate of 9.49% is consistent with reported mortality rates of other large series using 30-day mortality, 19 adding validity to the data reported in the NIS database, and our use of in-hospital mortality as an outcome. In addition, it has been argued that for complex operations, in-hospital mortality may be a better measure of postoperative mortality than 30-day mortality because of improved capabilities of intensive care management to rescue critically ill patients.
11
Other outcomes, such as complications associated with surgery or perioperative care and postdischarge outcomes, including deaths occurring outside of the surgical hospitalization, are not ascertainable from this database. Complications occurring after surgery cannot be differentiated from comorbidities existing preoperatively. This prevents us from examining and comparing postoperative complications. In addition, because these patients have undergone esophagectomy for cancer, it would be meaningful to measure disease-free and overall survival. When calculating the Charlson Index we assume that preexisting conditions and those same conditions arising after surgery have the same impact on patient outcomes. Proxies of non-death hospital outcome, including the need for postoperative procedural intervention and length of hospital stay, have been used by others studying different databases. 20, 21 FIGURE 2. Graph showing the different mortality rates above and below each volume threshold. Squares indicate the mortality rates of hospitals with annual esophagectomy volumes for esophageal cancer less than the volume threshold. Triangles indicate the mortality rates of hospitals with annual esophagectomy volumes for esophageal cancer greater or equal to the volume threshold. The difference between each pair of mortality rates at a given annual hospital volume is statistically significant for all volume thresholds except more than 29 and 34. Associated data are listed in Table 2 . There has been much recent postulation as to factors that influence postoperative outcomes at the hospital level. These focus on processes of care, which may be associated with improved outcome after surgery. Billingsley and colleagues 21 have correlated improved outcomes after surgery for colon cancer with the presence of solid organ transplantation teams, as a proxy for patient care indices associated with improved postoperative outcomes. Other processes of care studied and correlated to improved outcomes include dedicated surgical intensive care units managed by dedicated intensive care specialists, 3, 22 patient safety initiatives, 23 and the use of multidisciplinary teams and standardized clinical care pathways at high-volume centers, for example. 24 We believe it is likely that these hospital-level processes of care are more readily available at high-volume centers, and as such, high-volume status may serve as a proxy for them in large administrative databases such as the NIS.
We show that, although there is a trend toward an inverse relationship between volume and mortality, volume is not sufficient for defining centers of excellence. Volume seems to function as an imperfect surrogate for other variables, which may better define centers of excellence, such as quality of dedicated intensive care, postoperative monitoring, clinical care pathways, and other processes of care. 20, 21, 25, 26 Additional work is needed to identify those variables associated with improved outcome after esophageal resection.
In addition, using a comparison of mortality rates and goodness of fit of different volume thresholds, we were unable to identify a clear, optimal volume threshold for improved outcomes after esophagectomy for esophageal cancer. We conclude that the use of volume thresholds alone for determining centers of excellence does not appropriately represent the variance in the data or necessarily guide appropriate decision making and should be avoided.
Discussion
Dr A. Pennathur (Pittsburgh, Penn). Dr Meguid, that was an excellent presentation and I congratulate you on your efforts to define a cutoff volume. Dr Meguid and colleagues from the Johns Hopkins Hospital have analyzed the outcomes of more than 3000 patients from more than 1000 hospitals derived from the NIS. They analyzed the variable of esophagectomy volume with the primary outcome being in-hospital mortality. Their main objective was to evaluate how valid hospital volume cutoffs are for defining centers of excellence. The number of esophagectomies performed in these hospitals ranged from a minimum of 1 to a maximum of 29. The median was somewhat lower, just 4 esophagectomies per year. The overall mortality rate was 9.9%. After using esophagectomy volume as a dichotomous variable initially, they went on to perform a goodness-of-fit model, concluding that they were unable to establish a cutoff value. They then concluded that volume cutoffs cannot be used to determine centers of excellence and further work is needed to investigate this.
Several large single-institution series have been published with remarkably low mortality rates, including your institution; ours, where in a series of 222 consecutive esophagectomies had a mortality rate of 1.4%; and excellent results from other larger series, such as those from Drs Orringer, Altorki, and Swanson, to name a few.
However, this relationship between esophagectomy volume and outcome is complex, with several factors playing a role. These factors include the surgeon volume, specialty training of the surgeon, comorbidities in the patient, and provision for critical care services. Adding to these factors is the case mix seen at a particular hospital, which may contribute. For example, the referral pattern of a private hospital may be much different than that of an inner-city hospital.
So my first question is, given the complexities of the volumeoutcome relationship, do you think it is possible that you can reduce this to a single number across all hospitals in the United States without taking into consideration other important factors, such as surgeon volume, expertise, and patient population?
Dr Meguid. The impetus for our study was the curiosity to see how the seemingly arbitrary cutoff of 13 fared against other volume cutoffs. We expected to see a dramatic difference in mortality rates, for instance, but were, quite frankly, shocked by the apparent lack of the difference between choosing 13 and any other volume cutoff.
As you point out, the relationship between individual and hospital operative volume and the processes of care and outcome is very complex. Unfortunately, it's difficult to study the effect of different processes of care because of lack of information available in these multi-institutional databases. Using a patient-focused database, such as the Society of Thoracic Surgeons' database, would be ideal; however, at the present time data are lacking for such analysis, and unfortunately, use of all of our own single-institution databases lends to bias.
Dr Pennathur. The second question is, did you first conduct an analysis of all the data in this particular cohort of patients to establish a functional relationship between mortality and volume in this cohort before dichotomizing these patients?
Dr Meguid. Yes, sir. Before dichotomizing the data at the different cutoff points, we did examine the unadjusted relationship between volume and in-hospital death and found this to be an inversely linear relationship. When we adjusted for age, patient gender, patient race, and patient comorbidities, we also saw that that persisted.
Dr Pennathur. The next thing is, using mortality as an outcome variable, how do you do a risk-adjusted mortality rate? For example, from your article, when the volume was greater than 10, the mortality rate was 5.3%. However, when the volume was greater than or equal to 29, the mortality was actually higher; it was 8.6%. Is this because sicker patients are going to high-volume hospitals? Perhaps a more useful reporting might be a risk-adjusted mortality rate.
Dr Meguid. Yes, I fully agree with you. In dichotomizing a continuous variable, one is combining all of the values below and above that cutoff into 2 values. As a result, the lowest mortality rate was observed at a volume cutoff of 10, but when the volume cutoff was raised, a lower mortality rate was not observed. Again, that's one of the prime complications of using a dichotomous model for continuous variables.
Dr Pennathur. Along the same lines, are you going to attempt to take other variables into consideration, such as nutritional status of patients, which has been shown to be important; socioeconomic status; specialty training of the surgeon, which has been show to be important; and elective versus emergent procedures, all of which are going to have an impact on mortality? Dr Meguid. Yes, I fully agree with you regarding the importance of these factors. Unfortunately, because of the administrative nature of the NIS database, one is unable to account for many germane factors, such as cancer staging, preoperative nutritional status, and neoadjuvant or postoperative chemo-and radiotherapy. One can control for gender, some patient demographics, which aren't necessarily specific to operative mortality, the Charlson Comorbidity Index, and some hospital demographics. This is, again, a big limitation with these administrative datasets.
Dr M. Jaklitsch (Boston, Massachusetts). I'm just deeply concerned that your highest output hospital was 29 cases per year, and we all know of excellent academic centers of excellence that do more than 29 per year. So either they are not in the database, the most sterling outcomes are not in this database, or they are in this database but with incomplete data. I don't know how you can draw conclusions from this if either 1 of those 2 cases is true.
Dr Meguid. Dr Jaklitsch, that's an excellent point. In fact, when we looked at a similar example using pancreatic resections, we found a similarly small range, and that motivated us at Johns Hopkins to look into why we don't find institutions with 100 resections per year. Subsequently, in this nationally representative sample, we find that a lot of the hospitals are lower-volume hospitals and we don't see a lot of the larger academic centers included every year in this database. So that is, again, a limitation specific to the NIS database.
Dr Jaklitsch. Dr D. Wood (Seattle, Wash). I have the same concern that Dr Jaklitsch expressed, but also a concern about how you have represented the conclusion. It would seem that volume is an important surrogate for mortality outcomes, yet you have found that there is not a good cutoff for volume. That does not mean that volume isn't important, which it sounds like in the conclusion. Rather, volume is very important; we just cannot create a cutoff to define an ''adequate'' volume. So I think that it is very important to refine the message, because policymakers, like Leapfrog, need a clear message that volume is important in terms of quality of outcomes, unless you think that this research disputes that premise.
Dr Meguid. Dr Wood, you have made an excellent point. I don't want to misrepresent our findings. Our findings are that a specific cutoff is an inappropriate way to determine centers of excellence. However, in this example, increased volume is correlated with decreased complications and mortality, and that should not be overlooked.
